In Vitro Research

Our research also focuses on the effects of bee venom on colon cancer, specifically using the CT26 cell line.

Our research investigates the effects of bee venom on pancreatic cancer, focusing on two key cell lines: KPC and Panc-1.

Our research also extends to investigating the effects of bee venom on renal adenocarcinoma, specifically using the Renca cell line.​

Our research focuses on investigating the effects of bee venom on various breast cancer cell lines, including E0771, 4T1, and MDA-MB-231. By studying these specific cell lines in vitro, we aim to understand how bee venom interacts with breast cancer cells, potentially inhibiting their growth or inducing cell death. This research could provide valuable insights into developing new, targeted treatments for breast cancer.

In addition to cancer cell lines, our research also examines the effects of bee venom on healthy cell lines, such as Bend.3, EaHy926, and 293T. Studying these cell lines is crucial for understanding the selectivity and safety profile of bee venom as a potential therapeutic agent.

Our bee venom demonstrates a stronger effect compared to melittin, highlighting its enhanced potency and efficacy.